Global Health & Medicine -> 2022 Vol.4(No.2)

Editorial
COVID-19 in Japan: An update on national policy, research, clinical practice, and vaccination campaign
Global Health & Medicine. 2022; 4(2):64-66.
Policy Forum
How did the Tokyo Metropolitan Government respond to COVID-19?
Global Health & Medicine. 2022; 4(2):67-70.
Reporting on the implementation to set up a "care and isolation facility" for mild COVID-19 cases in Tokyo
Global Health & Medicine. 2022; 4(2):71-77.
Review
Public health responses to COVID-19 in Japan
Global Health & Medicine. 2022; 4(2):78-82.
Long COVID: current status in Japan and knowledge about its molecular background
Global Health & Medicine. 2022; 4(2):83-93.
For safe and adequate blood purification therapy in severe COVID-19 ‒ what we have learned so far
Global Health & Medicine. 2022; 4(2):94-100.
Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan
Global Health & Medicine. 2022; 4(2):101-107.
Original Article
Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT
Global Health & Medicine. 2022; 4(2):108-115.
Trends in endotracheal intubation for patients with COVID-19 by emergency physicians
Global Health & Medicine. 2022; 4(2):116-121.
Poor prognosis of patients with severe COVID-19 admitted to an infectious disease intensive care unit during the pandemic caused by the Delta variant in Japan
Global Health & Medicine. 2022; 4(2):122-128.
Brief Report
Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in Japan
Global Health & Medicine. 2022; 4(2):129-132.
Communication
The first eleven cases of SARS-CoV-2 Omicron variant infection in Japan: A focus on viral dynamics
Global Health & Medicine. 2022; 4(2):133-136.
Correspondence
Promotion of proper use of anti-SARS-CoV-2 drugs and SARS-CoV-2 vaccines by hospital pharmacists and establishment of an adverse drug reaction reporting system
Global Health & Medicine. 2022; 4(2):137-140.
Letter
Adverse reactions and attitudes toward vaccines among young populations one month after receiving a second dose of mRNA-1273 in Japan
Global Health & Medicine. 2022; 4(2):141-143.
Establishment of an emergency regulatory approval system in Japan in response to the COVID-19 pandemic and challenges in developing domestically produced vaccines
Global Health & Medicine. 2022; 4(2):144-145.